(Q43108038)

English

Adherence to a fixed-dose combination of rosiglitazone/glimepiride in subjects switching from monotherapy or dual therapy with a thiazolidinedione and/or a sulfonylurea

scientific article published on 6 April 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

14 November 2017

Adherence to a fixed-dose combination of rosiglitazone/glimepiride in subjects switching from monotherapy or dual therapy with a thiazolidinedione and/or a sulfonylurea (English)

1 reference

Europe PubMed Central

14 November 2017

author name string

Sarah Thayer

1

1 reference

Europe PubMed Central

14 November 2017

Bhakti Arondekar

2

1 reference

Europe PubMed Central

14 November 2017

Carolyn Harley

3

1 reference

Europe PubMed Central

14 November 2017

Theodore E Darkow

4

1 reference

Europe PubMed Central

14 November 2017

language of work or name

0 references

publication date

6 April 2010

1 reference

Europe PubMed Central

14 November 2017

Annals of Pharmacotherapy

1 reference

Europe PubMed Central

14 November 2017

44

1 reference

Europe PubMed Central

14 November 2017

5

1 reference

Europe PubMed Central

14 November 2017

791-799

1 reference

Europe PubMed Central

14 November 2017

Economic costs of diabetes in the U.S. In 2007.

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1M426

21 January 2018

Standards of medical care in diabetes--2009.

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1M426

21 January 2018

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1M426

21 January 2018

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1M426

21 January 2018

Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1M426

21 January 2018

Effects of intensive glucose lowering in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1M426

21 January 2018

Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1M426

21 January 2018

Fixed-dose combinations improve medication compliance: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1M426

21 January 2018

Predictors of medication-refill adherence in an indigent rural population

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1M426

21 January 2018

Adherence to prescribed oral hypoglycaemic medication in a population of patients with Type 2 diabetes: a retrospective cohort study

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1M426

21 January 2018

The cost to health plans of poor glycemic control

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1M426

21 January 2018

Effect of improved glycemic control on health care costs and utilization

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1M426

21 January 2018

Adherence to oral antidiabetic therapy in a managed care organization: a comparison of monotherapy, combination therapy, and fixed-dose combination therapy

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1M426

21 January 2018

Adherence to a fixed-dose combination of rosiglitazone maleate/metformin hydrochloride in subjects with type 2 diabetes mellitus: a retrospective database analysis

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1M426

21 January 2018

Methods for evaluation of medication adherence and persistence using automated databases

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1M426

21 January 2018

Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1M426

21 January 2018

Patient adherence and reimbursement amount for antidiabetic fixed-dose combination products compared with dual therapy among Texas Medicaid recipients.

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1M426

21 January 2018

Polypharmacy and Medication Adherence in Patients With Type 2 Diabetes

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1M426

21 January 2018

Impact of fixed-dose combination drugs on adherence to prescription medications

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1M426

21 January 2018

Greater reductions in A1C in type 2 diabetic patients new to therapy with glyburide/metformin tablets as compared to glyburide co‐administered with metformin

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1M426

21 January 2018

Identifiers

10.1345/APH.1M426

1 reference

Europe PubMed Central

14 November 2017

1 reference

Europe PubMed Central

14 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43108038&oldid=1981160524"